* Cardio Diagnostics Holdings Inc CDIO.OQ reported
quarterly
breakeven results per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -9 cents. The mean expectation of two analysts
for the quarter was for a loss of 13 cents per share. Wall
Street expected results to range from -14 cents to -13 cents per
share.
* Revenue rose 458.9% to $5.31 thousand from a year ago;
analysts
expected $250.00 thousand.
* Cardio Diagnostics Holdings Inc's reported EPS for the
quarter
was breakeven results.
* The company reported a quarterly loss of $1.39 million.
* Cardio Diagnostics Holdings Inc shares had fallen by 2.1%
this
quarter and lost 44.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 50% in
the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Cardio
Diagnostics Holdings Inc is $6.00
This summary was machine generated from LSEG data April 2 at
05:26 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.13 0.00 Beat
Sep. 30 2023 -0.27 -0.16 Beat
Jun. 30 2023 -0.18 -0.39 Missed
Mar. 31 2023 -0.18 -0.11 Beat